anti-CEA (human) Rabbit Monoclonal (RM326)

RevMab Biosciences
Product Code: REV-31-1213-00
Product Group: Primary Antibodies
CodeSizePrice
REV-31-1213-00-R100100 ul£455.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Antibody Isotype: Rabbit IgG
Antibody Clonality: Recombinant Antibody
Antibody Clone: RM326
Regulatory Status: RUO
Target Species: Human
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunohistochemistry (IHC)
  • Western Blot (WB)
Shipping:
Blue Ice
Storage:
+4°C

Images

1 / 1
Immunohistochemical staining of formalin fixed and paraffin embedded human colon tissue section using anti-CEA rabbit monoclonal antibody (Clone RM326) at a 1:2000 dilution.

Immunohistochemical staining of formalin fixed and paraffin embedded human colon tissue section using anti-CEA rabbit monoclonal antibody (Clone RM326) at a 1:2000 dilution.

Further Information

Alternate Names/Synonyms:
CD66e
Concentration:
N/A
EClass:
32160000
Form (Short):
liquid
Formulation:
Liquid. 50% Glycerol/PBS with 1% BSA and 0.09% sodium azide.
Handling Advice:
Avoid freeze/thaw cycles.
Immunogen:
Native CEA protein purified from human liver tissue.
Long Description:
Recombinant Antibody. This antibody reacts to human CEA (Carcinoembryonic Antigen) (CD66e). Applications: WB, IHC, ELISA. Source: Rabbit. Liquid. 50% Glycerol/PBS with 1% BSA and 0.09% sodium azide. CEA (Carcino Embryonic Antigen; CD66e) is synthesized during development in the fetal gut and re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is a member of carcinoembryonic antigens, immunoglobulin supergene family and consists of a single N domain (structural homology to the immunoglobulin variable) and six immunoglobulin constant-like A (A1, A2, A3) and B domains (B1, B2, B3). Antibodies to CEA are useful in identifying the origin of various metastatic adenocarcinomas and in distinguishing pulmonary adenocarcinomas (60 to 70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA mediates cell adhesion via homophilic as well as heterophilic binding to other proteins of the subgroup. Multiple cellular activities have been attributed to CEA, including roles in the differentiation and arrangement of tissue three-dimensional structure, angiogenesis, apoptosis, tumor suppression, metastasis and the modulation of innate and adaptive immune responses.
NCBI, Uniprot Number:
P06731
Package Type:
Vial
Product Description:
CEA (Carcino Embryonic Antigen; CD66e) is synthesized during development in the fetal gut and re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is a member of carcinoembryonic antigens, immunoglobulin supergene family and consists of a single N domain (structural homology to the immunoglobulin variable) and six immunoglobulin constant-like A (A1, A2, A3) and B domains (B1, B2, B3). Antibodies to CEA are useful in identifying the origin of various metastatic adenocarcinomas and in distinguishing pulmonary adenocarcinomas (60 to 70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA mediates cell adhesion via homophilic as well as heterophilic binding to other proteins of the subgroup. Multiple cellular activities have been attributed to CEA, including roles in the differentiation and arrangement of tissue three-dimensional structure, angiogenesis, apoptosis, tumor suppression, metastasis and the modulation of innate and adaptive immune responses.
Purity:
Protein A purified.
Source / Host:
Rabbit
Specificity:
This antibody reacts to human CEA (Carcinoembryonic Antigen) (CD66e).
Transportation:
Non-hazardous
UNSPSC Category:
Primary Antibodies
UNSPSC Number:
12352203
Use & Stability:
Stable for at least 1 year after receipt when stored at -20°C.